Boeckh MJ - Search Results

1

Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.

Kampouri E, Zamora D, Kiem ES, Liu W, Ibrahimi S, Blazevic RL, Lovas EA, Kimball LE, Huang ML, Jerome KR, Ueda Oshima M, Mielcarek M, Zerr DM, Boeckh MJ, Krantz EM, Hill JA. Kampouri E, et al. Among authors: boeckh mj. Clin Microbiol Infect. 2023 Jul 31:S1198-743X(23)00354-3. doi: 10.1016/j.cmi.2023.07.026. Online ahead of print. Clin Microbiol Infect. 2023. PMID: 37532126

2

Comparison of MRC-5 and U-373MG astrocytoma cells for detection of cytomegalovirus in shell vial centrifugation cultures.

Boeckh M, Gleaves CA, Bindra R, Meyers JD. Boeckh M, et al. Eur J Clin Microbiol Infect Dis. 1991 Jul;10(7):569-72. doi: 10.1007/BF01967276. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1655434

3

Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation.

Boeckh M, Gooley TA, Reusser P, Buckner CD, Bowden RA. Boeckh M, et al. J Infect Dis. 1995 Oct;172(4):939-43. doi: 10.1093/infdis/172.4.939. J Infect Dis. 1995. PMID: 7561213

4

Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation.

Boeckh M, Stevens-Ayers T, Bowden RA. Boeckh M, et al. J Infect Dis. 1996 Nov;174(5):907-12. doi: 10.1093/infdis/174.5.907. J Infect Dis. 1996. PMID: 8896489

5

Cytomegalovirus disease occurring before engraftment in marrow transplant recipients.

Limaye AP, Bowden RA, Myerson D, Boeckh M. Limaye AP, et al. Clin Infect Dis. 1997 May;24(5):830-5. doi: 10.1093/clinids/24.5.830. Clin Infect Dis. 1997. PMID: 9142777

6

Circulating cytomegalovirus (CMV)-infected endothelial cells in marrow transplant patients with CMV disease and CMV infection.

Salzberger B, Myerson D, Boeckh M. Salzberger B, et al. J Infect Dis. 1997 Sep;176(3):778-81. doi: 10.1086/517300. J Infect Dis. 1997. PMID: 9291332

7

Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia.

Boeckh M, Gooley TA, Bowden RA. Boeckh M, et al. J Infect Dis. 1998 Oct;178(4):1153-7. doi: 10.1086/515673. J Infect Dis. 1998. PMID: 9806049 Clinical Trial.

8

Recent advances in the therapy and prevention of CMV infections.

Nichols WG, Boeckh M. Nichols WG, et al. J Clin Virol. 2000 Feb;16(1):25-40. doi: 10.1016/s1386-6532(99)00065-7. J Clin Virol. 2000. PMID: 10680738 Review.

9

Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients.

Limaye AP, Huang ML, Leisenring W, Stensland L, Corey L, Boeckh M. Limaye AP, et al. J Infect Dis. 2001 Feb 1;183(3):377-82. doi: 10.1086/318089. Epub 2000 Dec 27. J Infect Dis. 2001. PMID: 11133368

10

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes.

Nichols WG, Corey L, Gooley T, Drew WL, Miner R, Huang M, Davis C, Boeckh M. Nichols WG, et al. Blood. 2001 Feb 15;97(4):867-74. doi: 10.1182/blood.v97.4.867. Blood. 2001. PMID: 11159510 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page